A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Latest

Latest news, 21 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

OPTIMAL-DIABETES: systolic target below 120 mmHg does not significantly cut CV events in type 2 diabetes

In a Brazilian trial of 9,476 adults with type 2 diabetes and hypertension, aiming for systolic BP below 120 mmHg did not significantly reduce major cardiovascular events versus a target below 140 mmHg, and kidney events were more frequent.

Healio
DiabetologyDiabetology

Sleep coaching adds no glucose benefit in prediabetes, but earlier sleep onset tracks with weight loss

In a 196-person randomised trial in adults with prediabetes and short sleep, adding a sleep intervention to lifestyle coaching did not improve CGM glucose; in a post hoc analysis, earlier sleep onset was linked to greater weight loss.

Medical Dialogues
NephrologyNephrology

Topical vancomycin cuts sternal wound infection after cardiac surgery without raising AKI in RCT

In a 360-patient randomised trial, vancomycin paste on sternal edges lowered grade 2 or higher wound infection versus saline without a significant rise in acute kidney injury, but dialysis patients showed higher blood levels.

Medical Dialogues
NeurologyNeurology

Pooled analysis of three RCTs: thrombectomy for distal vessel stroke gives no benefit, more bleeding

A pooled analysis of DISTAL, ESCAPE-MeVO and DISCOUNT found routine thrombectomy for medium or distal vessel occlusion stroke did not improve functional independence and more than doubled symptomatic intracranial haemorrhage.

NeurologyLive
UrologyUrology

Meta-analysis links higher triglyceride-glucose index to prostate cancer risk and mortality, mostly in Asians

A meta-analysis of seven studies with about 582,000 participants associated a higher TyG index, a marker of insulin resistance, with greater prostate cancer risk and cancer-specific death, with the strongest signal in Asian studies.

Medical Dialogues
PsychiatryPsychiatry

Non-invasive temporal interference brain stimulation eases subclinical depression in sham-controlled trial

In a randomised, double-blind, sham-controlled trial of 69 adults with subclinical depressive symptoms, three days of 10 Hz transcranial temporal interference stimulation aimed at a reward circuit lowered depression scores more than sham at one week.

Medical Dialogues
PulmonologyPulmonology

Metformin started within six days of COVID-19 linked to lower long COVID or death in target trial emulation

A US electronic health record analysis emulating a trial found that adults started on metformin within six days of a COVID-19 diagnosis had about half the six-month risk of long COVID or death compared with users of other repurposed drugs.

Medical Dialogues
Critical CareCritical Care

CHEST Critical Care review: bicarbonate as a bridge, not a cure, for severe acidaemia with AKI in the ICU

A CHEST Critical Care review says sodium bicarbonate may be a temporary bridge for selected ICU patients with severe metabolic acidaemia and moderate-to-severe AKI, reducing dialysis use but not mortality, while urgent indications still need RRT.

Medical Dialogues
GastroenterologyGastroenterology

PCR on archived gastric biopsies flags H. pylori DNA in 63% of histology-negative samples in Israeli study

In 830 archived gastric biopsies, PCR detected H. pylori DNA in 302 of 476 samples reported negative on histology. Authors caution that DNA does not prove live infection and suggest reviewing unresolved cases rather than replacing histology.

Medical Dialogues
DermatologyDermatology

Peripheral neuropathy found in nearly one in five patients with dermatomyositis in US cohort

In 640 patients with dermatomyositis at one US centre, 18.8% had peripheral neuropathy without another obvious cause. Most nerve studies showed an axonal pattern, and the authors call neuropathy an underrecognised feature of the disease.

JAMA Dermatology
OphthalmologyOphthalmology

Conjunctival autograft beats mitomycin C and amniotic membrane for pterygium recurrence in a 750-patient RCT

In a Chinese multicentre trial of primary pterygium excision, one-year recurrence was 5.0% with conjunctival autograft, 13.7% with intraoperative mitomycin C and 22.9% with amniotic membrane transplant.

JAMA Ophthalmology
ENTENT

GLP-1 receptor agonist use linked to better overall survival in head and neck squamous cell cancer

In a US records-network cohort of 4,532 adults with head and neck squamous cell carcinoma, GLP-1 receptor agonist users had about half the five-year mortality hazard of matched controls. The data are observational and do not show cause.

JAMA Otolaryngology-Head & Neck Surgery
OrthopaedicsOrthopaedics

Meta-analysis of RCTs: arthroscopic and mini-open repair give similar results in small-to-medium cuff tears

Pooling seven randomised trials covering 725 shoulders, researchers found no meaningful differences in function, pain, motion, re-tear, stiffness or infection between all-arthroscopic and mini-open repair for small to medium full-thickness rotator cuff tears.

Medical Dialogues
GynaecologyGynaecology

About 1 in 10 women screen positive for PTSD symptoms two months after induced vaginal delivery

A French multicentre cohort of 794 women found PTSD symptoms in 10.6% two months after induced vaginal birth, with higher odds after cervical ripening, fetal indications for induction and haemorrhage of 1,000 mL or more.

Medical Dialogues
PaediatricsPaediatrics

ADHD classroom accommodations such as extra time and breaks show no benefit in JAMA Pediatrics trial

In a crossover trial of 255 children with ADHD, extended time, frequent breaks, low-distraction seating and standing desks did not improve behaviour or work output, while stimulant medication and behaviour therapy did.

JAMA Pediatrics
SurgerySurgery

SEER-Medicare analysis: surgery's edge over SBRT in stage IA lung cancer shrinks after bias correction

In 4,251 older patients with stage IA NSCLC, the apparent lung cancer mortality advantage of sublobar resection over SBRT narrowed sharply once unmeasured confounding was addressed, though a smaller benefit with surgery remained.

JAMA Surgery
General MedicineGeneral Medicine

Genetically attenuated whole-parasite malaria vaccine protects 13 of 15 volunteers in early challenge trial

A phase 1 controlled human malaria infection study of the PfSPZ-LARC2 vaccine reported protection in 13 of 15 vaccinated adults (87%) versus none of 7 placebo recipients, including against a divergent Brazilian parasite strain.

Medical Dialogues
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team